Tissue-specific expression and hybrid plant production

Patent metadata

Field	Value
Publication number	US-10683513-B2
Application number	US-201414577887-A
Country	US
Kind code	B2
Filing date	Dec 19, 2014
Priority date	Dec 31, 2013
Publication date	Jun 16, 2020
Grant date	Jun 16, 2020

Abstract

This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in male plant tissues, for example, to provide an economical male sterility system of hybrid seed production.

First claim

What may be claimed is:

1. A nucleic acid molecule comprising a coding sequence operably linked to a plant promoter, wherein the coding sequence comprises the internal small ribonucleic acid (sRNA) target site of SEQ ID NO:8.

2. The nucleic acid molecule of claim 1 , wherein the molecule is a vector.

3. The nucleic acid molecule of claim 2 , wherein the vector is a plant expression vector or plant transformation vector.

4. The nucleic acid molecule of claim 1 , wherein the coding sequence is an herbicide tolerance coding sequence or a selectable marker coding sequence.

5. The nucleic acid molecule of claim 1 , wherein the plant promoter is sugarcane bacilliform virus (SCBV) promoter.

6. A transgenic plant cell comprising the nucleic acid molecule of claim 1 .

7. A transgenic plant tissue or plant part comprising the nucleic acid molecule of claim 1 .

8. The transgenic plant tissue or plant part of claim 7 , wherein expression of the coding sequence is reduced or eliminated in male plant tissues.

9. The transgenic plant tissue or plant part of claim 7 , wherein the plant tissue or plant part is a seed.

10. A transgenic plant comprising the nucleic acid molecule of claim 3 .

11. The transgenic plant of claim 10 , wherein expression of the coding sequence is reduced or eliminated in at least one tissue of the plant.

12. The transgenic plant of claim 11 , wherein expression of the coding sequence is reduced or eliminated in a tissue-specific or tissue-preferred manner.

13. The transgenic plant of claim 12 , wherein expression of the coding sequence is reduced or eliminated in male plant tissues.

14. The transgenic plant of claim 13 , wherein the coding sequence is an herbicide tolerance coding sequence, and wherein application of the herbicide to the plant kills male tissues in the plant.

15. A method for producing a transgenic plant cell, the method comprising transforming a plant cell with the nucleic acid molecule of claim 1 .

16. The method according to claim 15 , the method further comprising:
culturing the transformed plant cell to produce a transgenic plant cell or transgenic tissue culture of transgenic plant cells comprising the coding sequence operably linked to the plant promoter; and
regenerating a transgenic plant from the transgenic plant cell or transgenic tissue culture.

Assignees

• Dow Agrosciences Llc

Inventors

• Kumar Sandeep
• German Marcelo Ariel
• Coram Tristan
• Wright Terry R

Classifications

• Y02A40/146

  Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title

• C12N15/8231

  Male-specific, e.g. anther, tapetum, pollen · CPC title

• C12N15/8222

  Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation · CPC title

• C12N15/8289

  Male sterility · CPC title

• C12N15/8274

  for herbicide resistance · CPC title